Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study


Brouwer W. P. , Chan H. L. Y. , Lampertico P., Hou J., Tangkijvanich P., Reesink H. W. , ...Daha Fazla

CLINICAL INFECTIOUS DISEASES, cilt.69, ss.1969-1979, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 69 Konu: 11
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1093/cid/ciz084
  • Dergi Adı: CLINICAL INFECTIOUS DISEASES
  • Sayfa Sayıları: ss.1969-1979

Özet

Background. (Pegylated) Interferon ([Peg]IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand.